» Articles » PMID: 29088923

Oxidative Modifications in Tissue Pathology and Autoimmune Disease

Overview
Specialty Endocrinology
Date 2017 Nov 2
PMID 29088923
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Significance: Various autoimmune syndromes are characterized by abnormalities found at the level of tissues and cells, as well as by microenvironmental influences, such as reactive oxygen species (ROS), that alter intracellular metabolism and protein expression. Moreover, the convergence of genetic, epigenetic, and even environmental influences can result in B and T lymphocyte autoimmunity and tissue pathology. Recent Advances: This review describes how oxidative stress to cells and tissues may alter post-translational protein modifications, both directly and indirectly, as well as potentially lead to aberrant gene expression. For example, it has been clearly observed in many systems how oxidative stress directly amplifies carbonyl protein modifications. However, ROS also lead to a number of nonenzymatic spontaneous modifications including deamidation and isoaspartate modification as well as to enzyme-mediated citrullination of self-proteins. ROS have direct effects on DNA methylation, leading to influences in gene expression, chromosome inactivation, and the silencing of genetic elements. Finally, ROS can alter many other cellular pathways, including the initiation of apoptosis and NETosis, triggering the release of modified intracellular autoantigens.

Critical Issues: This review will detail specific post-translational protein modifications, the pathways that control autoimmunity to modified self-proteins, and how products of ROS may be important biomarkers of tissue pathogenesis.

Future Directions: A clear understanding of the many pathways affected by ROS will lead to potential therapeutic manipulations to alter the onset and/or progression of autoimmune disease.

Citing Articles

The role of oxidative post-translational modifications in type 1 diabetes pathogenesis.

Alhamar G, Vinci C, Franzese V, Tramontana F, Le Goux N, Ludvigsson J Front Immunol. 2025; 16:1537405.

PMID: 40028329 PMC: 11868110. DOI: 10.3389/fimmu.2025.1537405.


CD4+ T Cells From Individuals With Type 1 Diabetes Respond to a Novel Class of Deamidated Peptides Formed in Pancreatic Islets.

Callebaut A, Guyer P, Derua R, Buitinga M, Manganaro A, Yi X Diabetes. 2024; 73(5):728-742.

PMID: 38387030 PMC: 11043062. DOI: 10.2337/db23-0588.


Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia.

Chae S, Kim Y, Park C Antioxidants (Basel). 2023; 12(12).

PMID: 38136203 PMC: 10740440. DOI: 10.3390/antiox12122083.


Natural isoaspartyl protein modification of ZAP70 alters T cell responses in lupus.

Yang M, Lam T, Kanyo J, Kang I, Zhou Z, Clarke S Autoimmunity. 2023; 56(1):2282945.

PMID: 37994408 PMC: 10897934. DOI: 10.1080/08916934.2023.2282945.


Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example.

Lichti C, Wan X Semin Immunol. 2023; 66:101730.

PMID: 36827760 PMC: 10324092. DOI: 10.1016/j.smim.2023.101730.


References
1.
Meissner T, Krause E, Lodige I, Vinkemeier U . Arginine methylation of STAT1: a reassessment. Cell. 2004; 119(5):587-9. DOI: 10.1016/j.cell.2004.11.024. View

2.
Huebscher K, Lee J, Rovelli G, Ludin B, MATUS A, Stauffer D . Protein isoaspartyl methyltransferase protects from Bax-induced apoptosis. Gene. 1999; 240(2):333-41. DOI: 10.1016/s0378-1119(99)00443-6. View

3.
Strickland F, Richardson B . Epigenetics in human autoimmunity. Epigenetics in autoimmunity - DNA methylation in systemic lupus erythematosus and beyond. Autoimmunity. 2008; 41(4):278-86. PMC: 2819669. DOI: 10.1080/08916930802024616. View

4.
Hu N, Qiu X, Luo Y, Yuan J, Li Y, Lei W . Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol. 2008; 35(5):804-10. View

5.
Nguyen H, James E . Immune recognition of citrullinated epitopes. Immunology. 2016; 149(2):131-8. PMC: 5011684. DOI: 10.1111/imm.12640. View